approval
saveGLEEVEC (IMATINIB MESYLATE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalJan 14, 2026 · 303d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 1, 2024 · 987d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 19, 2022 · 1547d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 24, 2022 · 1695d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020 · 2286d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020 · 2286d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 21, 2018 · 3006d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalSep 6, 2017 · 3355d ago
same company · ±60 days · 5
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalSep 15, 2017
- approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalSep 6, 2017
- approvalZOLEDRONIC ACID — FDA approvalOct 27, 2017
- approvalOXCARBAZEPINE: TRILEPTAL (OXCARBAZEPINE) — FDA approvalNov 17, 2017
- approvalOXCARBAZEPINE: TRILEPTAL (OXCARBAZEPINE) — FDA approvalNov 17, 2017
comments(0)
5-min edit window · permanent after that